COVID-19: EU Assessing Booster Dose Of Pfizer/BioNTech’s Comirnaty
Inflammatory Syndrome Side-Effect Also Under Investigation
As the debate continues over whether booster vaccines will be required to sustain waning immune responses in the general population, the EU regulator says it should have the results of its assessment of an application for a booster dose of Cominarty in the next few weeks.
